FDC Regulatory Approval

Results Update

FDC Results Update

FDC Limited reports Q2 FY27 revenue of Rs. 572 crore, up 21%, and EBITDA of Rs. 64 crore. Domestic formulations grew 22.6% and international formulations rose 28.5%.

Financial Results

FDC Q2 FY27 Results: Net Profit ₹49.1 Cr, Up 72.9% YoY

FDC Ltd reported revenue from operations of ₹572.1 Cr (+21.0% YoY) and net profit of ₹49.1 Cr (+72.9% YoY) for Q2 FY27.

Key figure

Net profit ₹49.1 Cr · +72.9% YoY

Capital Structure Change

FDC Capital Structure Change

FDC's board approved a buyback of up to ₹120 Crore at ₹500 per share via tender offer. The record date is November 13, 2026.

Value

₹120.0 Cr

Board Meeting Date

FDC Board Meeting Date

FDC Limited scheduled a board meeting for October 27, 2026, to discuss financial results and a proposed buyback.

Other Announcement

FDC Other Announcement

FDC Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.

Annual General Meeting

FDC Annual General Meeting

FDC Limited issued a corrigendum to its 86th AGM notice, correcting the e-voting cut-off date to September 17, 2026. This also updates the book closure dates.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.